查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
败血症诊断市场：趋势、机会与竞争分析 [2023-2028]
市场调查报告书
商品编码
1341988

败血症诊断市场：趋势、机会与竞争分析 [2023-2028]

Sepsis Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

脓毒症诊断市场趋势与预测

预计到 2028 年，全球败血症诊断市场将达到 10 亿美元，2023 年至 2028 年年复合成长率为 8.1%。该市场的主要促进因素包括脓毒症诊断研究活动的公共和私人资金增加、感染疾病风险上升、脓毒症发病率增加以及政府配合措施提高公众脓毒症意识。全球败血症诊断市场前景广阔，医院/诊所、病理/标准实验室和研究所市场蕴含商机。

败血症诊断市场洞察

  • Lucintel 认为，由于人口高龄化、血流感染疾病增加以及临床医生越来越多地采用最简单、最经济有效的检测方法，血液培养基将在预测期内成为最大的细分市场。我们预测这将继续成为案子。
  • 在这个市场中，医院和诊所是最大的细分市场，因为到医院就诊的罹患患者数量不断增加，各种疾病导致的死亡人数不断增加，以及可用于脓毒症诊断和治疗的各种设备的可得性。 。
  • 由于医疗基础设施完善、先进诊断解决方案的采用不断增加以及败血症和感染疾病罹患率的增加，北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球脓毒症诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

  • 宏观经济趋势（2017-2022）与预测（2023-2028）
  • 全球败血症诊断市场趋势（2017-2022）与预测（2023-2028）
  • 按产品的全球脓毒症诊断市场
    • 乐器
    • 血培养基
    • 检测试剂盒和试剂
    • 软体
  • 按技术分類的全球脓毒症诊断市场
    • 微生物学
    • 分子诊断
    • 免疫学测试
    • 流式细胞仪
    • 其他的
  • 按最终用途产业分類的全球脓毒症诊断市场
    • 医院和诊所
    • 病理学和参考实验室
    • 调查机构
    • 其他的

第4章2017-2028年分地区市场趋势及预测分析

  • 全球败血症诊断市场（按地区）
  • 北美败血症诊断市场
  • 欧洲败血症诊断市场
  • 亚太地区脓毒症诊断市场
  • 其他区域脓毒症诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品的全球脓毒症诊断市场成长机会
    • 全球脓毒症诊断市场的技术成长机会
    • 全球脓毒症诊断市场成长机会（按最终用途行业）
    • 按地区分類的全球脓毒症诊断市场成长机会
  • 全球脓毒症诊断市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球脓毒症诊断市场的产能
    • 全球败血症诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • bioMerieux SA
  • Becton, Dickinson & Company
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Luminex
  • Cepheid
  • Bruker Corporation
  • Immunexpress
  • Koninklijke Philips
简介目录

Sepsis Diagnostic Market Trends and Forecast

The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets. The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028 with a CAGR of 8.1% from 2023 to 2028. The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.

A more than 150-page report is developed to help in your business decisions.

Sepsis Diagnostic Market by Segment

The study includes trends and forecast for the global sepsis diagnostic market by product, technology, end use industry, and region, as follows:

Sepsis Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Instruments
  • Blood Culture Media
  • Assay Kits and Reagents
  • Software

Sepsis Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Others

Sepsis Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals & Clinics
  • Pathology & Reference Laboratories
  • Research Institutes
  • Others

Sepsis Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Sepsis Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, sepsis diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sepsis diagnostic companies profiled in this report include:

  • bioMerieux SA
  • Becton, Dickinson & Company
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Luminex
  • Cepheid
  • Bruker Corporation
  • Immunexpress
  • Koninklijke Philips

Sepsis Diagnostic Market Insights

  • Lucintel forecasts that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
  • Within this market, hospitals & clinics will remain the largest segment due to growing number of patients visit in hospitals suffering from sepsis, huge number of fatalities caused by various illnesses, and the availability of various equipment, which can be used for sepsis diagnostic treatments.
  • North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region

Features of the Sepsis Diagnostic Market

  • Market Size Estimates: Sepsis diagnostic market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Sepsis diagnostic market size by various segments, such as by product, technology, end use industry, and region
  • Regional Analysis: Sepsis diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different products, technologies, end use industries, and regions for the sepsis diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the sepsis diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q1. What is the sepsis diagnostic market size?
  • Answer: The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028.
  • Q2. What is the growth forecast for sepsis diagnostic market?
  • Answer: The global sepsis diagnostic market is expected to grow with a CAGR of 8.1% from 2023 to 2028.
  • Q3. What are the major drivers influencing the growth of the sepsis diagnostic market?
  • Answer: The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.
  • Q4. What are the major segments for sepsis diagnostic market?
  • Answer: The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets.
  • Q5. Who are the key sepsis diagnostic companies?
  • Answer: Some of the key sepsis diagnostic companies are as follows:
    • bioMerieux SA
    • Becton, Dickinson & Company
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • Danaher
    • Luminex
    • Cepheid
    • Bruker Corporation
    • Immunexpress
    • Koninklijke Philips
  • Q6. Which sepsis diagnostic segment will be the largest in future?
  • Answer:Lucintel forecast that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
  • Q7. In sepsis diagnostic market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region.
  • Q8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global sepsis diagnostic market by product (instruments, blood culture media, assay kits and reagents, and software), technology (microbiology, molecular diagnostics, immunoassays, flow cytometry, and others), end use industry (hospitals & clinics, pathology & reference laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Sepsis Diagnostic Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Sepsis Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Sepsis Diagnostic Market by Product
    • 3.3.1: Instruments
    • 3.3.2: Blood Culture Media
    • 3.3.3: Assay Kits and Reagents
    • 3.3.4: Software
  • 3.4: Global Sepsis Diagnostic Market by Technology
    • 3.4.1: Microbiology
    • 3.4.2: Molecular Diagnostics
    • 3.4.3: Immunoassays
    • 3.4.4: Flow Cytometry
    • 3.4.5: Others
  • 3.5: Global Sepsis Diagnostic Market by End Use Industry
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Pathology & Reference Laboratories
    • 3.5.3: Research Institutes
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Sepsis Diagnostic Market by Region
  • 4.2: North American Sepsis Diagnostic Market
    • 4.2.1: North American Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
    • 4.2.2: North American Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
  • 4.3: European Sepsis Diagnostic Market
    • 4.3.1: European Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
    • 4.3.2: European Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
  • 4.4: APAC Sepsis Diagnostic Market
    • 4.4.1: APAC Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
    • 4.4.2: APAC Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
  • 4.5: ROW Sepsis Diagnostic Market
    • 4.5.1: ROW Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
    • 4.5.2: ROW Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Sepsis Diagnostic Market by Product
    • 6.1.2: Growth Opportunities for the Global Sepsis Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for the Global Sepsis Diagnostic Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Sepsis Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Sepsis Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Sepsis Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sepsis Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: bioMerieux SA
  • 7.2: Becton, Dickinson & Company
  • 7.3: Thermo Fisher Scientific
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Danaher
  • 7.6: Luminex
  • 7.7: Cepheid
  • 7.8: Bruker Corporation
  • 7.9: Immunexpress
  • 7.10: Koninklijke Philips